Efficacy of Single-Pill Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg in Patients with Cardiovascular Disease Risk Factors: A Prospective Subgroup Analysis of a Randomized, Double-Blind, and Controlled Trial

Objective. Report of prespecified and post hoc subgroup analyses of a randomized, controlled trial comparing telmisartan 80 mg/hydrochlorothiazide 25 mg (T80/H25) combination therapy with T80 monotherapy, according to the presence of cardiovascular disease (CVD) risk factors. Methods. Hypertensive p...

Descripción completa

Detalles Bibliográficos
Autores principales: Bays, Harold, Gao, Pingjin, Völker, Birgit, Mattheus, Michaela, Ruilope, Luis M., Zhu, Dingliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638649/
https://www.ncbi.nlm.nih.gov/pubmed/23653855
http://dx.doi.org/10.1155/2013/749830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638649/
https://www.ncbi.nlm.nih.gov/pubmed/23653855
http://dx.doi.org/10.1155/2013/749830

Ejemplares similares